Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $385000.0.

  • Bioharvest Sciences' Depreciation & Amortization (CF) rose 968.66% to $385000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 3605.68%. This contributed to the annual value of $1.3 million for FY2024, which is 4892.86% up from last year.
  • Latest data reveals that Bioharvest Sciences reported Depreciation & Amortization (CF) of $385000.0 as of Q3 2025, which was up 968.66% from $407000.0 recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' Depreciation & Amortization (CF) peaked at $407000.0 during Q2 2025, and registered a low of $202000.0 during Q1 2024.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $351000.0 (2024), whereas its average is $319444.4.
  • Examining YoY changes over the last 5 years, Bioharvest Sciences' Depreciation & Amortization (CF) showed a top increase of 9752.48% in 2025 and a maximum decrease of 968.66% in 2025.
  • Over the past 3 years, Bioharvest Sciences' Depreciation & Amortization (CF) (Quarter) stood at $216000.0 in 2023, then skyrocketed by 57.87% to $341000.0 in 2024, then grew by 12.9% to $385000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $385000.0 in Q3 2025, compared to $407000.0 in Q2 2025 and $399000.0 in Q1 2025.